SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001477932-24-002350
Filing Date
2024-04-26
Accepted
2024-04-26 16:09:58
Documents
13
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 PRE 14A vnrx_pre14a.htm PRE 14A 771461
2 vnrx_pre14aimg39.jpg GRAPHIC 148258
3 vnrx_pre14aimg38.jpg GRAPHIC 169799
4 vnrx_pre14aimg37.jpg GRAPHIC 204774
5 vnrx_pre14aimg36.jpg GRAPHIC 166148
6 vnrx_pre14aimg31.jpg GRAPHIC 45210
7 vnrx_pre14aimg30.jpg GRAPHIC 50392
8 vnrx_pre14aimg29.jpg GRAPHIC 2992
9 vnrx_pre14aimg26.jpg GRAPHIC 4468
10 vnrx_pre14aimg25.jpg GRAPHIC 4833
11 vnrx_pre14aimg24.jpg GRAPHIC 4428
12 vnrx_pre14aimg23.jpg GRAPHIC 4449
13 vnrx_pre14aimg19.jpg GRAPHIC 20699
  Complete submission text file 0001477932-24-002350.txt   1912264
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36833 | Film No.: 24883737
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)